NO has important physiological functions in plants, including the adaptative response to pathogen attack. We previously demonstrated that cryptogein, an elicitor of defence reaction produced by the oomycete Phytophthora cryptogea, triggers NO synthesis in tobacco. To decipher the role of NO in tobacco cells elicited by cryptogein, in the present study we performed a proteomic approach in order to identify proteins undergoing S-nitrosylation. We provided evidence that cryptogein induced the S-nitrosylation of several proteins and identified 11 candidates, including CDC48 (cell division cycle 48), a member of the AAA+ ATPase (ATPase associated with various cellular activities) family. In vitro, NtCDC48 (Nicotiana tabacum CDC48) was shown to be poly-S-nitrosylated by NO donors and we could identify Cys 110 , Cys 526 and Cys 664 as a targets for S-nitrosylation. Cys 526 is located in the Walker A motif of the D2 domain, that is involved in ATP binding and was previously reported to be regulated by oxidative modification in Drosophila. We investigated the consequence of NtCDC48 S-nitrosylation and found that NO abolished NtCDC48 ATPase activity and induced slight conformation changes in the vicinity of Cys 526 . Similarly, substitution of Cys 526 by an alanine residue had an impact on NtCDC48 activity. More generally, the present study identified CDC48 as a new candidate for S-nitrosylation in plants facing biotic stress and further supports the importance of Cys 526 in the regulation of CDC48 by oxidative/nitrosative agents.
INTRODUCTION
NO is a diatomic free radical gas that regulates many plant physiological processes, such as germination, root growth, regulation of stomatal closure and of pollen tube growth, flowering, leaf senescence, iron homoeostasis and environmental responses [1] . However, detailed knowledge of the mechanisms underlying the effects of NO is still lacking. Several signalling components acting downstream of NO have been identified, including protein kinases, ROS (reactive oxygen species), cGMP, Ca 2 + and lipids [1] [2] [3] . The interplay operating between NO and these signal transducers is complex and still under investigation.
The concept that NO regulates biological processes through the direct or indirect chemical modification of amino acid residues has also gained much attention. Notably, S-nitrosylation has emerged as an important post-translational modification of proteins. S-nitrosylation designs the covalent and reversible attachment of an NO moiety to the sulfhydryl group of cysteine residues. This process leads to altered protein function, and over 200 proteins undergoing S-nitrosylation have been identified in animals [4] . S-nitrosylation has been linked to a broad range of physiological and pathological functions, highlighting the functional relevance of this post-translational modification of proteins. In plants, studies in which plant tissues, organelles or protein extracts were exposed to artificially released NO led to the identification of many proteins representing candidates for S-nitrosylation [5] [6] [7] [8] . Further studies characterized the 'S-nitrosylome' in different biological backgrounds, including, for instance, plant defence responses [9] , cold [10] and salt stress [11, 12] . These studies emphasized the importance of S-nitrosylation as a physiological NO-based process in plants. In parallel, analyses of the incidence of S-nitrosylation on specific proteins provided a tight mechanistic view of the impact of NO on their activities and how NO can mediate its biological effects [13] [14] [15] [16] . Interestingly, several of these proteins were related to defence responses in Arabidopsis thaliana. This includes PrxIIE (peroxiredoxin II E) [17] , non-expressor of pathogenesis-related gene 1 [18] , SABP3 (salicylic acid-binding protein 3) [19] , the transcription factor TGA1 [20] and the NADPH oxidase AtRBOHD (A. thaliana RBOHD) [16] . S-nitrosylation of critical cysteine residues within these proteins was shown to promote or inhibit the formation of disulphide linkages and to induce changes in their conformation, thus altering their activities. S-nitrosylation of NPR1 at residue Cys 156 facilitates its oligomerization in an inactive form [18] , whereas S-nitrosylation of TGA1 positively affects its DNA-binding activity, possibly by protecting the protein from the formation of a disulfide bond involving Cys 172 and Cys 287 [20] . Regarding PrxIIE, SABP3 and AtRBOHD, S-nitrosylation occurs on catalytic cysteine residues or cysteine residues involved in co-factor binding. S-nitrosylation of Cys 890 of AtRBOHD triggers the reorientation of Phe 921 , involved in the binding of the cofactor FAD [16] . This process diminishes FAD binding and therefore impairs AtRBOHD enzymatic activity. Similarly, S-nitrosylation of Cys 280 of SABP3 reduces both its enzymatic activity and its ability to bind salicylic acid [19] . In the case of PrxIIE, S-nitrosylation of Cys 121 inhibits the hydroperoxide-reducing peroxidase activity of the protein, leading to enhanced production of peroxynitrite, a NO-derived oxidant promoting tyrosine nitration of proteins [17] .
Cryptogein is a 10 kDa proteinaceous elicitor produced by the oomycete Phytophthora cryptogea, an avirulent pathogen of tobacco [21] . Upon application to tobacco, cryptogein induces a HR (hypersensitive response) together with a SAR (systemic acquired resistance) against various pathogens, including Phytophthora parasitica var. nicotianae, the causal agent of the black shank disease [21] . Key components of the cryptogein-induced signalling pathway leading to defence responses and controlling HR development have been identified [22] [23] [24] . Interestingly, cryptogein was also shown to promote a fast NO synthesis in both tobacco plants and in cell suspensions. NO production was detected at the intracellular and extracellular levels [25] [26] [27] , but also in the gas phase from elicited tobacco cells [28] . We provided evidence previously that NO partly mediates the increase in the cytosolic free Ca 2 + concentration ([Ca 2 + ] cyt ) induced by cryptogein in tobacco cells [26] , supporting a role of NO as a Ca 2 + -mobilizing compound as reported in other physiological contexts [29] . Beside this function, the role of NO in cryptogein signalling is still enigmatic.
The aim of the present study was to identify and characterize S-nitrosylated proteins in tobacco cells exposed to cryptogein in order to further decipher the role of NO in the signalling cascade triggered by this elicitor. Using the BST (biotin switch technique) in conjunction with MS analysis, 11 proteins were identified as targets for S-nitrosylation. We focused our work on the chaperone-like NtCDC48 [Nicotiana tabacum CDC48 (cell division cycle 48)], a member of the AAA+ ATPase (ATPase associated with various cellular activities) family, whose orthologue in vertebrates corresponds to the p97/VCP (vasolincontaining protein). NtCDC48 was shown to undergo poly-Snitrosylation in vitro. This process involved Cys 526 , a residue evolutionally conserved in p97/VCP/CDC48s of multicellular, but not unicellular, organisms [30] . Cys 526 is located in the Walker A motif of the D2 domain of the protein involved in ATP binding. Accordingly, S-nitrosylation of CDC48 abolished CDC48 ATPase activity and induced local conformational changes in the vicinity of Cys 526 . More generally, the present study provides CDC48 as a new candidate for S-nitrosylation in plants and further supports a role for Cys 526 in the regulation of p97/VCP-CDC48 ATPases by oxidative/nitrosative stresses.
EXPERIMENTAL

Cell culture
N. tabacum cv. Xanthi cell suspensions were cultivated as described previously [27] . Cell were maintained in the growth exponential phase and subcultured 1 day prior to use. For experiments, 7-day-old tobacco cell suspensions were used.
Treatments
Cryptogein was purified according to Bonnet et al. [21] and dissolved in water as a 100 μM stock solution. Cells were treated with a final concentration of 100 nM of cryptogein. DEA/NO (diethylamine-NONOate; Enzo Life Sciences) was prepared daily as a 500 mM stock solution in 0.01 M NaOH. To initiate the release of NO, 10 μl of the stock alkaline solution of DEA/NO was dissolved in 990 μl of 100 mM phosphate buffer, pH 7.2, maintained at room temperature (20 • C) to give a 5 mM final concentration. GSNO (S-nitrosoglutathione; Enzo Life Science) and GSH (Sigma-Aldrich) were prepared freshly before use in ultrapure water at a 5 mM final concentration.
Biotin-switch assays
The BST was performed according to Jaffrey et al. [31] with some changes. After cryptogein treatment, cells (0.25 g) were harvested by filtration, frozen in liquid nitrogen and ground in a mortar. Samples were mixed with 400 μl of HEN buffer (25 mM Hepes/NaOH, pH 7.7, 1 mM EDTA, 0.1 mM neocuproine, 2 mM PMSF, 10 μM antipain and 10 μM leupeptin) with 0.5 % CHAPS and centrifuged at 14 000 g for 20 min. The protein concentration in the supernatant was quantified using the Protein Assay System described by Bradford [32] . Protein concentration was adjusted to 0.8 μg/μl in a final volume of 800 μl by addition of HEN buffer. Samples were then treated by the addition of freshly prepared MMTS [methyl methanethiosulfonate, 2 M in DMF (dimethylformamide)] and SDS (25 %, v/v) to final concentrations of 20 mM and 2.5 % respectively, and incubated for 20 min at 50
• C. All the steps were performed in half-light. Proteins were then precipitated with 10 vol. of acetone at − 20
• C for 20 min, before centrifugation at 3700 g for 12 min. After washing (3 vol. of 80% acetone), the pellets were suspended in 10 μl of HEN buffer containing 1 % SDS per 100 μg of starting material of proteins and mixed with 1 mM biotin-HPDP {N- [6-(biotinamido) hexyl]-3 -(2 -pyridyldithio)propionamide, Thermo Scientific, dissolved in DMF} and 1 mM ascorbate. For control samples, the corresponding volume of DMF and ascorbate were added. Labelling reactions were performed at room temperature in the dark for 90 min. Proteins were then precipitated by addition of 10 vol. of acetone at − 20
• C for 20 min, followed by a centrifugation at 14 000 g for 12 min at 4
• C. The pellets were resuspended in 62 μl of 25 mM Tris/HCl, pH 6.8, buffer containing 1 % SDS. The protein concentrations were then assayed using 2 μl, before the addition of 60 μl of 2× modified Laemmli buffer [126 mM Tris/HCl, pH 6.8, 4 % (w/v) SDS, 20 % (v/v) glycerol and 0.12 % Bromophenol Blue]. Proteins (100 μg) were then analysed by SDS/PAGE followed by immunoblotting with alkaline phosphatase-coupled anti-biotin antibodies (1:7500 dilution, Sigma-Aldrich). For specific CDC48 detection, Western blots were performed using anti-CDC48 antibodies (from Professor Sebastian Bednarek, Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, U.S.A.; 1:10000 dilution) followed by the addition of peroxidasecoupled anti-chicken antibodies (1:10000 dilution, Euromedex).
MS analysis for the identification of S-nitrosylated proteins
Biotin switch-treated samples (100 μg) were digested using 1 μg of EndoLysC endoprotease (Sigma-Aldrich) over 16 h at 37
• C. The lysate was applied to a cation exchange column (Applied Biosystems) in a phosphate buffer [10 mM KH 2 PO 4 and 25 % (v/v) acetonitrile, pH 3] and eluted using the same buffer supplemented with 350 mM KCl. Biotinylated peptides were then purified on a 1 ml avidin column (Applied Biosystems) according to the manufacturer's instructions. Elution fractions were concentrated using a SpeedVac, resuspended in 10 μl of 0.1 % TFA (trifluoroacetic acid) and submitted to trypsin digestion for 2 h at 50
• C. The resulting peptides were analysed using a trap mass spectrometer (Esquire HCT; Bruker) interfaced with an HPLC chip system (Agilent). MS/MS (tandem MS) data were searched against NCBI (National Center for Biotechnology Information) databases using Mascot software.
Cloning of cDNAs encoding NtCDC48 and NtCDC48(C526A)
cDNAs encoding NtCDC48 was obtained by RT (reverse transcription)-PCR with total RNA isolated from tobacco cell suspensions. RNA was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Firststrand cDNA was synthesized using 1 μg of total RNA as a template with the SuperScript III Reverse Transcriptase kit (Invitrogen). The cDNA was used for PCR amplification of NtCDC48 with primer pair 5 -CACCATGACTAACAAAG-CTGAATCCTCC-3 and 5 -CTAACTATACAGGTCATCTTCA-TCTGC-3 designed on the basis of nucleotide sequences available in databases. NtCDC48(C526A) full-length cDNA was obtained by site-directed mutagenesis using the primers 5 -CCACCTGGAgcTGGGAAAAC-3 and 5 -GTTTTCCCAgcTCCAGGTGG-3 . All the PCR reactions were performed using the high-fidelity Phusion DNA polymerase (Finnzyme). PCR products corresponding to full-length cDNA of NtCDC48 and NtCDC48(C526A) were cloned into the pENTR/D/TOPO vector (Invitrogen) and verified by DNA sequencing.
Expression and purification of recombinant proteins in Escherichia coli
Full-length cDNAs encoding NtCDC48 and NtCDC48(C526A) were introduced into the pHGWA vector (a gift from Dr Didier Busso, Institut de la Génétique et de la Biologie Moléculaire et Cellulaire, University of Strasbourg, Strasbourg, France [33] ) using the GATEWAY LR Clonase kit (Invitrogen) according to the manufacturer's instructions. Constructions were verified by sequencing and used to transformed E. coli Rosetta strain (Novagen). Bacteria were grown at 37
• C in LB (Luria-Bertani) medium to a D 600 of 0.5 and then expression was induced by addition of IPTG (isopropyl β-D-thiogalactopyranoside; SigmaAldrich) at 750 μM (final concentration) at 20
• C over 20 h. Recombinant proteins were purified using the His Trap FF column (GE Healthcare) according to the manufacturer's instructions. Elution fractions were analysed on SDS/PAGE and protein concentrations were assayed using the method described by Bradford [32] .
Three-dimensional structure prediction
The three-dimensional structure of CDC48 was predicted in silico using the modelling software SWISS-MODEL [34] and I-TASSER [35] .
Measurement of CDC48 activity
Activity tests were performed as described previously [36] . Briefly, 1 μg of recombinant CDC48 protein suspended in 100 mM Tris/HCl, 6 mM MgCl 2 and 2 mM KCl, pH 7.4, was treated or not with increasing concentrations of DEA/NO or GSNO for 20 min in the dark. In some assays, 5 mM DTT (dithiothreitol) was added to reverse the effects of GSNO. Then, 0.2 mM of ATP was added to the reaction mixture in a final volume of 25 μl. After 10 min of incubation, 80 μl of freshly prepared Malachite Green reactive solution was added to the samples, followed by 10 μl of 34 % sodium citrate solution. Samples were then incubated for 15 min at room temperature before measuring the absorbance at 650 nm.
CD and fluorescence analyses
The spectroscopic analyses were performed in a JASCO J-815 spectropolarimeter equipped with a Peltier temperature control unit and an FMO427 fluorescence detection unit. The CD measurements were carried out in a 0.2 cm pathlength cuvette (50 nm/min scan speed, 4 s response time, 2 nm band width, 0.1 nm/s data pitch) with an average of three scans for each spectrum at a wavelength range of 195-280 nm. The measurements for fluorescence were carried out in a 1 cm cuvette using 295 nm as excitation wavelength and scanning the fluorescence emission over the range 300-400 nm. All protein samples were concentrated to 2 μM. For nitrosylation experiments, both NtCDC48 and NtCDC48(C526A) were incubated with GSNO at 125 μM for 15 min at 25
• C in the dark. Subsequently, the S-nitrosylated protein samples were submitted to the spectroscopic evaluations.
Melting experiments
The thermal unfolding accompanied by CD was performed increasing the temperature of the cuvette in a slope of 0.5
• C per min from 25-80
• C. The unfolding was detected by decrease of CD signal at 222 nm. Data were collected at 0.1 nm intervals. The calculations were performed according to eqn (1) followed by eqn (2): 
where θ is the ellipticity in degrees, l is the optical path in cm, C is the concentration of sample in mg/ml, M is the molecular mass and n is the number of residues in the protein.
Analysis of Cys 526 biotinylation
Recombinant CDC48 protein was treated with GSNO (125 μM) or GSH (125 μM) as described above and then subjected to the BST. After application of the BST, approximately 100 μg of the biotinylated proteins were submitted to trypsinization over 16 h at 37 • C using 10 ng/μl trypsin in 50 mM NH 4 HCO 3 , pH 7.5. Digested peptides were separated by reverse-phase chromatography with an ultra-fast chromatograph (Shimadzu's Prominence ® UFLC) connected to a C 18 column (Shimadzu ShimPack XR ODS, 2.0 mm internal diameter×30 mm, 2.2 μm) using a water/acetonitrile (5-90 %, 30 min) gradient. The fractions were collected manually, frozen at − 70
• C for 30 min and then dried under vacuum for 1 h. The dried fractions were suspended in 10 μl of matrix solution (α-4-cian-hydroxycinamic acid, 5 mg/ml in 50 % acetonitrile and 3 % TFA) and spotted in triplicate in a polished steel MTP 384 MALDI (matrix-assisted laser-desorption ionization) plate. MALDI-TOF-MS (MALDI-time-of-flight MS) analysis was performed using a Bruker spectrometer (Autoflex III Smartbeam ® ) equipped with a 200 Hz pulsed nitrogen laser Tobacco cell suspensions were treated with cryptogein (100 nM), collected at the indicated times and the corresponding protein extracts were subjected to the BST. Proteins (100 μg) were then separated by SDS/PAGE. Detection of biotinylated proteins was achieved by immunoblotting with alkaline phosphatase-coupled anti-biotin antibodies. The sample on the left-hand side (-MMTS) corresponds to proteins extracted from cryptogein-treated tobacco subjected to the BST without MMTS; the sample on the right-hand side (-Biotin) corresponds to proteins extracted from cryptogein-treated tobacco subjected to the BST without biotin-HPDP. M, molecular mass markers; masses are indicated on the left-hand side in kDa. The experiment was repeated a dozen times with similar results.
emitting at 337 nm. The extraction voltage was 20 kV and all spectra were recorded under delayed extraction conditions and in the reflector mode, improving mass accuracy and resolution. Spectra were also acquired with deflector mode (400 Da) and each spectrum represents an average of 300 single laser shots. The search and identification of global modifications, including biotinylation, were performed using Biotools ® software (Bruker Daltonics).
RESULTS
Cryptogein treatment leads to the S-nitrosylation of several proteins
In light of previous findings showing that cryptogein triggers NO production in tobacco cell suspensions [25] [26] [27] , we sought to investigate NO functions by identifying its target proteins. Specifically, we examined whether cryptogein could trigger the S-nitrosylation of proteins. To explore this possibility, we used the BST initially developed by Jaffrey et al. [31] (see also [13] ). In this three-step method, after blocking free cysteine thiols by methylthiolation with MMTS, the cysteine-bound NO (S-NO) are removed by ascorbate and replaced with biotin-HPDP to enable the purification and/or the detection of the proteins of interest.
Protein extracted at different time points during cryptogein treatment of tobacco cell suspensions were subjected to the BST and analysed by immunoblotting using anti-biotin antibodies. To validate the specificity of the method, the BST was performed without adding biotin-HPDP or MMTS. As shown in Figure 1 , approximately ten immunoreactive bands were detected in the samples corresponding to cryptogein treatment. The intensity of these bands peaked at 5 min and decreased within 120 min. This observation fits well with our previous data showing that cryptogein triggers a fast and transient NO production in tobacco cell suspensions [27] . In contrast, the immunoreactive bands were not, or poorly, detected in samples corresponding to the control cells not exposed to the elicitor.
In the cryptogein-treated samples subjected to the BST, but in which biotin-HPDP was omitted, almost no bands were observed. Therefore, the detection of the immunoreactive bands in the cryptogein samples did not reflect inducible biotinylation of proteins. Furthermore, omission of MMTS led to a strong signal testifying the biotinylation of many cysteine residues, thus highlighting the efficiency of MMTS as a blocking reagent. Taken together, these results suggest that cryptogein induces a fast and reversible S-nitrosylation of several proteins.
Identification of the S-nitrosylated proteins
To identify the proteins undergoing S-nitrosylation, proteins extracted from cells exposed to cryptogein for 5, 15, 30, 60 or 90 min were mixed and subjected to the BST. The resulting biotinylated proteins were digested by EndoLysC treatment and then purified by affinity chromatography using avidin columns. Digestion by EndoLysC was performed in order to optimize the efficiency of the purification step on avidin columns. Next, the purified biotinylated peptides were subjected to tryptic digestion, analysed by ESI-MS (electrospray ionization MS) MS/MS and identified using the Mascot search engine. Three independent biological replicates were analysed according to this procedure. Table 1 lists the 11 peptides specifically identified from the cryptogein-treated samples. These peptides were commonly identified in the three independent biological replicates. Four peptides contain a cysteine residue harbouring the biotin tag. These residues represent the putative target for S-nitrosylation. Furthermore, three of the identified proteins, namely CDC48, the ATP synthase subunit α and the 60S ribosomal protein L7A-like, have been previously reported as putative targets for S-nitrosylation.
In terms of cellular function, two of these proteins are related to energy and metabolism. Beside the ATP synthase subunit α mentioned above, this includes acetohydroxy acid isomeroreductase, involved in amino acid biosynthetic pathways. Also identified were a CaM (calmodulin) and a putative CDPK (Ca 2 + -dependent protein kinase), which act as intermediates in Ca 2 + signalling, a putatively cell wall-associated GRP (glycine-rich protein) and three proteins with unknown function. Interestingly, the list shown Table 1 also contains CDC48, a member of the AAA+ ATPase family. CDC48, named p97 in vertebrates, is a conserved chaperone-like AAA+ ATPase assembling into a stable homohexamere. CDC48 plays multiple roles in animals and yeast, such as targeting of ubiquitinylated proteins for degradation by the proteasome, initiation of DNA replication or homotypic fusion of endoplasmic reticulum and Golgi membranes [37] . In plants, CDC48 function has been less studied, but several investigations pointed out its involvement in growth, development, cell division and protein degradation [38, 39] .
Peptides identified in both cryptogein and control samples (eight peptides), identified specifically in control samples (20 peptides) or in tobacco protein extracts in which the BST was performed without adding biotin-HPDP (17 peptides) are listed in Supplementary Table S1 (at http://www.BiochemJ.org/ bj/447/bj4470249add.htm). For each treatment, these peptides were commonly identified in three independent replicates. Most of the corresponding proteins are related to energy and metabolism and, of these, 42 % have previously been shown to be S-nitrosylated in other studies. The identification of 17 proteins in the samples in which biotin-HPDP was omitted highlights the relatively poor sensitivity of the immunoblotting shown in Figure 1 , as no immunoreactive polypeptide was detected in the Table 1 List of proteins undergoing S-nitrosylation in response to cryptogein Protein extracted from cryptogein-treated tobacco cells were subjected to the BST, purified by affinity chromatography using avidin columns and analysed by ESI-MS MS/MS after trypsic digestion. The Mascot search engine was used to parse the MS data to identify proteins from the primary sequence database (significant threshold: 20, P < 0.05). Protein putative functions were determined according to http://www.geneontology.org. The Table lists corresponding lane. The majority of these proteins (ten) were also detected in the cryptogein and/or control samples and were considered as false positives.
Recombinant NtCDC48 undergoes poly-S-nitrosylation
The proteins listed in Table 1 are all candidates for S-nitrosylation.
To investigate the effects of S-nitrosylation on their activities and structure, we selected CDC48 as a model protein. Indeed, beside the processes described above, CDC48 was shown to interact with SERK1 (somatic embryogenesis receptor-like kinase 1) in A. thaliana [40] . In rice, the SERK1 orthologue was reported to contribute to the resistance against the pathogenic fungus Magnaporthe grisea [41] , thus highlighting a putative role for CDC48 in the signalling processes inherent to plant immunity. The presence of the putative S-nitrosylated cysteine residue in the corresponding peptide identified in MS, as well as the measurable enzymatic activity of this protein, also accounted for this choice.
A 2.4 kb full-length cDNA encoding CDC48 was cloned by a PCR-based strategy using total RNA isolated from tobacco cell suspensions as a template and appropriate primers designed using sequences available in databases. NtCDC48 cDNA encodes a protein of 808 residues with a predicted size of 89.9 kDa and a pI of 5.13. The deduced protein sequence contains the peptide identified in MS analysis (residues 517-528), the cysteine residue of interest being located on position 526 ( Figure 2A ). NtCDC48 had 93 %, 77 % and 67 % identity with the A. thaliana, human and yeast CDC48 isoforms respectively. Similarly to its orthologues, NtCDC48 consists of four domains: the N-terminal domain, involved in the binding to cofactors and ubiquitinated substrates; the D1 domain, possessing an ATPase activity and mediating the oligomerization of the enzyme; the D2 domain, displaying the major ATPase activity; and the C-terminal domain, also involved in the binding of cofactors and subjected to posttranslational modifications, notably phosphorylation [42] . Both the D1 and D2 domains (also named AAA+ ATPase domains) contain Walker A and Walker B motifs involved in the binding and hydrolysis of the β-γ phosphate bond of ATP respectively. Cys 526 is located in the Walker A motif (residues 522-530) of the D2 domain.
A prediction of the three-dimensional structure of the NtCDC48 monomer was performed with SwissModel [34] using the crystal structure of Mus musculus CDC48 [43, 44] as a template ( Figure 2B ). In this model, both the D1 (lefthand part of the protein) and D2 (right-hand part of the protein) domains of NtCDC48 bind ATP and, as reported for the M. musculus isoform, have an overall similar shape. These domains are joined by a 20 residue linker (residues 465-484). According to this model, Cys 526 is located in the In order to investigate the effect of NO on NtCDC48, we first checked whether the protein could be S-nitrosylated in vitro. For this purpose, NtCDC48 was introduced into the expression vector pHGWA [33] and the resulting His-tagged protein was produced in the E. coli Rosetta strain and subsequently purified. A recombinant mutated NtCDC48 protein in which Cys 526 was replaced by an alanine residue [NtCDC48(C526A)] was similarly produced. The identity of the recombinant proteins was verified by Western blotting analysis using polyclonal antibodies raised against A. thaliana CDC48 (Supplementary Figure S2 at http://www.BiochemJ.org/bj/447/bj4470249add.htm). S-nitrosylation of NtCDC48 was surveyed by the BST after treatment of the recombinant proteins with the NO donor GSNO. As negative controls, the recombinant proteins were exposed to GSH. As shown in Figure 3(A) , immunostaining using anti-biotin antibodies indicated that the recombinant Wt (wild-type) protein undergoes S-nitrosylation in response to GSNO. Interestingly, exposure to GSNO also resulted in the S-nitrosylation of the mutated recombinant protein, but to a lower extent. Indeed, quantification of the corresponding band showed that, compared with the Wt recombinant protein, the level of S-nitrosylation of the mutated protein was reduced by almost 50 % (Figure 3B ). The presence of faint bands in the lanes corresponding to GSH treatments confirmed that the signal detected in response to GSNO was due to NO. Taken together, these data demonstrate that NtCDC48 undergoes S-nitrosylation in vitro. Furthermore, the reduced S-nitrosylation level of the mutated protein suggests that Cys 526 is directly regulated by S-nitrosylation, but also that other cysteine residues are probably targeted by this post-translational modification.
To confirm the S-nitrosylation of Cys 526 , after application of the BST, approximately 100 μg of the recombinant CDC48 was submitted to proteolysis with trypsin and the corresponding peptides were analysed by MALDI-TOF-MS ( Figure 3C ). The spectra of the digested non-S-nitrosylated CDC48 protein showed a 17 residue peptide of m/z 1251.170 (residues 517-533) containing carbamidomethyl-Cys 526 . The spectra of S-nitrosylated CDC48 protein showed the same 17 residue peptide, but of m/z 1625.964, displaying a mass shift corresponding to biotynil-Cys 526 . These data further support our hypothesis that Cys 526 undergoes S-nitrosylation. Supporting the assumption that other cysteine residues might undergo S-nitrosylation upon treatment of the recombinant protein with GSNO, two other cysteine residues were found to be biotinylated in MS analysis (Supplementary Figure S3 at (Figure 2A ).
Figure 4 NO inhibits NtCDC48 ATPase activity
Effect of GSNO and DEA/NO on the ATPase activity of NtCDC48 and NtCDC48(C526A). A total of 1 μg of recombinant NtCDC48 or NtCDC48(C526A) was pre-incubated with GSNO (100, 500 or 1000 μM) or DEA/NO (100, 500 or 1000 μM) for 20 min in the dark and then subjected to the ATPase assay using ATP (0.2 mM) as a substrate. The amount of phosphate released was quantified by spectrophotometry at 650 nm. The experiment was performed four times with three replicates per experiment. Significant differences were determined by an ANOVA followed by a Turkey test. The asterisks indicate values statistically different from those observed with the Wt untreated NtCDC48 protein (**P < 0.01, ***P < 0.001).
Importantly, this residue was found to be constitutively S-nitrosylated in AtCDC48a, one of the three CDC48 isoforms in A. thaliana [12] . Regarding Cys 664 , this residue is located in the D2 domain, but appears to be less conserved as it was not found in the human and yeast CDC48 isoforms (Figure 2A ).
NO affects NtCDC48 ATPase activity
The location of Cys 526 in the D2 domain of NtCDC48 led us to analyse whether NO could affect the ATPase activity of the recombinant protein. The recombinant Wt protein displayed a quantifiable ATPase activity measured by determining the amount of phosphate released (Figure 4) . GSNO significantly reduced this activity in a dose-dependent manner, the maximum inhibition being observed with 500 μM of GSNO. The NO-induced inhibition of NtCDC48 ATPase activity could be partly reversed using the reducing agent DTT, suggesting that GSNO affects NtCDC48 activity through a reversible thiol modification (Supplementary Figure  S4 at http://www.BiochemJ.org/bj/447/bj4470249add.htm). To strengthen these data, the effect of a second NO donor, DEA/NO, was assessed. Similarly to GSNO, DEA/NO triggered a concentration-dependent reduction of NtCDC48 ATPase activity. We also analysed the ATPase activity of the recombinant mutated protein NtCDC48(C526A) as well as its sensitivity to NO. NtCDC48(C526A) showed a low ATPase activity representing only 20 % of the activity catalysed by Wt NtCDC48. Treatment of NtCDC48(C526A) with GSNO or DEA/NO did not significantly reduce the residual activity of the mutated protein.
Collectively, these results demonstrate that NO readily affects NtCDC48 ATPase activity and highlights a key role for Cys 526 in the enzymatic activity of the protein. The inefficiency of NO donors to reduce the ATPase activity of the mutated protein further reinforces the assumption that Cys 526 is regulated by Snitrosylation.
NO did not affect NtCDC48 secondary structure and thermal stability
We next investigated whether NO could impact the secondary structure of NtCDC48 using CD spectroscopy. The structure of the protein was predicted using the K2D algorithm. The CD spectrum of NtCDC48 is shown Figure 5(A) . The fractions of the residues of NtCDC48 involved in α-helices, β-sheets and random coils represent 43, 12 and 45 % respectively. The mutated recombinant protein NtCDC48(C526A) displayed the same CD spectrum. Treatment of NtCDC48 with GSNO did not alter the CD spectra of both the Wt and the mutated proteins, suggesting that NO did not appreciably change their secondary structure ( Figure 5B) .
To complete this analysis, we estimated the impact of NO and of the C526A mutation on the thermal stability of NtCDC48. The thermal stability was assessed by following the reduction of the CD signal at 222 nm upon increasing temperature ( Figure 5C ). NtCDC48 displays a melting temperature of 49.2
• C, which was not modified by NO treatment (Table 2) . Interestingly, the mutated recombinant protein NtCDC48(C526A) showed a reduced melting temperature of 46.3
• C (Table 2 and Figure 5C ). Thus this physical parameter was also not modified by NO treatment.
Taken together, these data indicate that NO neither affected the overall secondary structure of NtCDC48 nor its melting temperature. However, the C526A mutation decreased the thermal stability of the protein.
Effects of NO on NtCDC48 conformation
NtCDC48 contains two tryptophan residues located at positions 480 and 555 (Figure 2A ). Both tryptophan residues are spatially close to Cys 526 as shown in Figure 6 (A), representing the predicted structure surrounding Cys 526 . To analyse whether NO could affect the conformation of NtCDC48, the intrinsic fluorescence of the tryptophan residues was determined. Upon excitation at 295 nm, NtCDC48 exhibits a fluorescence emission spectrum with a maximum at approximately 333 nm, typical for tryptophan residues ( Figure 6B ). Treatment of NtCDC48 with GSNO, but not GSH, reduced the fluorescence intensity to approximately 15 % at 333 nm ( Figure 6C ), suggesting that NO triggers subtle conformational changes in the vicinity of the tryptophan residues. The reduction of fluorescence induced by GSNO was not reversed when the thiol reductant DTT was added after the NO donor treatment (Supplementary Figure S5 at http://www.BiochemJ.org/bj/447/bj4470249add.htm).
Compared with NtCDC48, the mutated NtCDC48(C526A) displayed a reduced yield of fluorescence ( Figure 6B) . Furthermore, the fluorescence spectra of NtCDC48(C526A) showed a shift of the maximum of fluorescence to a lower wavelength. Therefore, the C526A mutation appears to locally impact the conformational integrity of CDC48. Interestingly, a reduction of the fluorescence intensity also occurred when NtCDC48(C526A) was exposed to GSNO ( Figure 6D ), pointing out a NO-dependent structural alteration of the mutated protein.
DISCUSSION
Previous studies showed that cryptogein triggers a fast and transient NO production in tobacco leaf as well as in cell suspensions [25] [26] [27] [28] . Although pharmacological approaches provided evidence that NO acts as a signalling component contributing to cryptogein-induced free Ca 2 + mobilization and defence gene expression, the functions of NO are poorly understood. To help address this, we set out an experimental approach to identify proteins susceptible to S-nitrosylation in tobacco cells challenged by cryptogein.
We used the classical BST [31] , but included a digestion step with EndoLysC before the purification of the biotinylated proteins by affinity chromatography. This enzymatic digestion allows the generation of polypeptides easier to purify on the avidin column compared with native proteins, thus optimizing the efficiency of the purification step. However, this procedure also reduced the number of peptides detectable for each protein in the MS analysis, as only the biotinylated peptides, and not the corresponding whole proteins, were purified. Therefore it is noteworthy that the candidates listed in the present study result mainly from the detection of only one peptide. Next, the purified biotinylated peptides were subjected to tryptic digestion. Depending on the number and the position of the lysine and arginine residues, this step generated two types of smaller peptides: peptides containing the biotinylated cysteine residue and peptides without this residue, but which were contiguous to the biotinylated peptide in the primary sequence of the corresponding protein. Therefore, depending on the protein, either biotinylated or non-biotinylated peptides were identified in the MS analysis. We were able to identify 11 protein candidates for S-nitrosylation in response to cryptogein treatment. The corresponding peptides were commonly identified from three independent biological replicates. Similar approaches have been used to identify plant proteins undergoing S-nitrosylation in response to NO donors and, in some cases, in physiological contexts [13, 45] . Interestingly, the list of the candidate proteins includes a CaM and a CDPK, two proteins related to Ca 2 + signalling. In animals, NO was reported to inhibit the brain Ca 2 + /CaM-dependent protein kinase I and II through S-nitrosylation, this process being correlated to neurotoxicity [46] . In plants, the possibility that CaM or CDPK might be sensitive to S-nitrosylation has not been reported so far. This finding is particularly relevant as it further strengthen previous studies showing that NO is intimately linked to the Ca 2 + signalling operating in tobacco cells challenged by cryptogein, but also by other stresses such as osmotic stress [1, 29] . The other candidate proteins are correlated to amino acid metabolism, protein synthesis or do not display characterized functions. Among them, the ATP synthase subunit α and the 60S ribosomal protein L7A-like were previously reported to be putatively regulated through S-nitrosylation in plants, but the impact of this post-translational modification on their function and/or structure were not investigated.
In addition to those proteins, NtCDC48 was also identified as being putatively S-nitrosylated in response to cryptogein. In animals and yeast, CDC48 is a hexameric AAA+ ATPase involved in multiple cellular processes, including membrane fusion, the ubiquitin-proteasome degradation pathway, the ERAD (endoplasmic reticulum-associated degradation) pathway, cell cycle control or apoptosis [37, 42, 47, 48] . In plants, CDC48 activity and/or expression has been associated with the ERAD pathway, disease resistance, cytokinesis, cell expansion and differentiation [39, 49, 50] . At the post-transcriptional level, data from the animal field indicate that CDC48 is prone to phosphorylation and acetylation. These processes modulate partner binding and subcellular localization of the protein [51] . Furthermore, a regulation of CDC48 by oxidative modification has been proposed [30] .
Primary sequence alignment indicates that NtCDC48 is highly conserved among various species and consists of four domains, including the classical D1 and D2 domains, each containing the Walker A and B motifs that bind and hydrolyse ATP. The peptide identified in the MS analysis is located within the Walker A motif of the D2 domain and contains Cys 526 . Following the application of the BST, this residue was found to be biotinylated in the MS analysis both in cryptogein-treated cells and in the in vitro experiments, suggesting that it is probably targeted by S-nitrosylation. Further supporting this assumption, the comparative quantification of S-nitrosylation between NtCDC48 and NtCDC48(C526A) showed a reduced level of S-nitrosylation in the mutated recombinant protein. This residue already deserved particular attention. Indeed, in the Drosophila CDC48 isoform, Cys 522 (corresponding to Cys 526 in NtCDC48) was identified as the site responsible for the inhibition of the ATPase activity conferred by ROS and reactive nitrogen species, including GSNO [30] . Interestingly, Noguchi et al. [30] also noted that this cysteine residue is evolutionarily conserved in multicellular but not unicellular organisms. They hypothesized that the occurrence of this cysteine residue in the Walker A motif must have conferred certain advantages to multicellular organisms.
Similarly to the study discussed above, we found that NO released by GSNO or DEA/NO inhibits NtCDC48 ATPase activity. Furthermore, the mutated NtCDC48(C526A) recombinant protein displayed a reduced ATPase activity. Taken together, these results point to a negative regulation of NtCDC48 in response to nitrosative agents and confirm that the D2 domain is responsible for the major ATPase activity. They also demonstrate the importance of Cys 526 in the regulation of NtCDC48 ATPase activity as reported for the Drosophila isoform [30] . In our prediction of the tertiary structure of NtCDC48 monomers, this residue is positioned in close vicinity to ATP. Although this position explains its involvement in NtCDC48 ATPase activity, its precise role remains unclear. In the majority of the members of the AAA+ ATPase class, including CDC48, the Walker A motif is conserved in the form of GXXGXGK[S/T] and the Walker B motif typically assumes the form hhhhDE (where h is a hydrophobic residue) (Figure 2 , see also Supplementary Figure  S6 at http://www.BiochemJ.org/bj/447/bj4470249add.htm). The lysine residue of the Walker A domain (Lys 528 in NtCDC48) supports the binding of nucleotides. The serine or threonine flanking residue (Thr 529 in NtCDC48), together with the aspartate residue (Asp 581 in NtCDC48) from the Walker B motif, are involved in co-ordinating a magnesium ion, which promotes catalysis. The second acidic residue of the Walker B motif (Glu 582 in NtCDC48) primes a water molecule for a nucleophilic attack on the γ -phosphate group of ATP during hydrolysis [52] . Other residues of the AAA+ ATPase domain, but which do not belong to the Walker A and B motifs, also appear to be crucial in ATP hydrolysis [53] . These residues are located in the so-called sensor 1 (residues 622-633 in NtCDC48), arginine finger (Arg 642 in NtCDC48) and sensor 2 (residues 687-695 in NtCDC48) motifs (Supplementary Figure S6) . According to these data, it is plausible that Cys 526 might not have a direct role in ATP catalysis. It is noteworthy that the C526A mutation resulted in a reduced thermal stability of the protein together with local structural alteration. These findings support a model in which Cys 526 plays a structural function and might mediate interactions that facilitate hydrolysis or ATP binding rather than ATP catalysis.
This discussion raises the question of how NO impacts NtCDC48 activity. In terms of protein structure, results from the CD spectroscopy and intrinsic fluorescence analysis indicated that treatment with NO did not alter the secondary structure content of NtCDC48, but triggered subtle conformational changes. The slight disruption of the structure induced by GSNO was not abolished by adding the reducing agent DTT to the S-nitrosylated protein, suggesting that NO does not promote this process through reversible thiol modification. On the other hand, DTT was able to reverse the NO-induced inhibition of NtCDC48 enzymatic activity. Taken together, these data indicate that the conformation change mediated by NO does not deeply impact NtCDC48 activity. It should be also mentioned that we verified, using gel filtration chromatography, that GSNO, as well as the Cys 526 mutation, did not affect the oligomerization of the protein into its hexameric structure (results not shown).
In the Drosophila isoform, Noguchi et al. [30] proposed that the oxidation of Cys 522 probably interferes with ATP binding to the protein through a mechanism of steric hindrance. In the case of NtCDC48, this process might also occur when Cys 526 becomes S-nitrosylated. However, the mode of action of NO on NtCDC48 should be also discussed in the light of the data showing that, in addition to Cys 526 , two additional cysteine residues (Cys 110 and Cys 664 ) undergo S-nitrosylation upon GSNO treatment of the recombinant protein (Figure 3 and Supplementary Figure  S3) . Cys 110 has been already found as being constitutively Snitrosylated in AtCDC48a, one of the three CDC48 isoforms in A. thaliana. Cys 664 belongs to the D2 domain, but is not located in the putative key motifs involved in ATP binding or hydrolysis (Supplementary Figure S6) . Importantly, in the MS analysis performed from cryptogein-treated tobacco cells, we did not detect biotinylated peptides containing Cys 110 and Cys 664 (Table 1) . Therefore whether the S-nitrosylation of Cys 110 and Cys 664 of NtCDC48 occurs in vivo and how the regulation of these residues by NO impacts NtCDC48 remain to be further investigated.
NO, together with ROS, have been suspected to be involved in the cryptogein-transduction pathway leading to defence responses in tobacco. However, no target proteins of nitrosative and/or oxidative stress have been identified. The present study identified NtCDC48 as one of these targets. NO promotes subtle conformational changes of NtCDC48 and inhibits its ATPase activity in vitro. Further investigation should shed light on the impact of NtCDC48 S-nitrosylation in plant defence.
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